117 results
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Structural Heart Disease pre-procedural sizing and planning tutorials: TAVR / TAVI
17 Aug 2022
In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-procedural sizing and planning in TAVR, Valve-in-Valve, re-do TAVR, alternate access and more.
Prognostic impact of extra–mitral valve cardiac involvement in patients with primary mitral regurgitation
17 Jun 2022
This report builds up the evidence on the relevance of extra-valvular cardiac damage staging / involvement as a main predictor of adverse events in patients with VHD undergoing intervention, either surgical or percutaneous.
Reviewer
Reviewer
Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial
16 Jun 2022
The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.
Reviewer
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE Neo2
09 Jun 2022
The ACURATE neo2 valve was developed to reduce the risk of paravalvular AR with an increased sealing skirt. This retrospective study aimed to compare TAVI with the ACURATE neo and neo2 devices.
Reviewer
Reviewer
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial
01 Jun 2022
The present study aimed at investigating a potential reduction of the HF hospitalization rate between 1 and 2 years after inclusion in the MITRA-FR trial.
Reviewer
Reviewer
Evolution and prognostic impact of cardiac damage after aortic valve replacement
24 May 2022
The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.
Reviewer
Angina: when coronary curtery is not the problem
19 May 2022 – From EuroPCR 2022
Don't miss this session focusing on angina by exploring 5 different cases, including a challenging graft aneurysm, a vein graft perforation after CABG not related to PCI and an unusual case of tortuosity in a two-year-old child...
Dealing with complex and high-risk interventions
18 May 2022 – From EuroPCR 2022
Thanks to these seven clinical cases, you will be able to learn how to manage risky and complex interventions, including a case of complex triple bifurcation lesions, a high-risk PCI case and a successful kissing balloon technique in transradial PCI.
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial
14 Feb 2022
The purpose of the prespecified subanalysis of the EXCEL (Evaluation of XIENCE versus Coronary artery bypass surgery for Effectiveness of Left main revascularization) trial was to determine whether the outcomes remained consistent regardless of geography.
Reviewer
Reviewer
